Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort.
OBJECTIVE
In patients with type 1 diabetes, there has been concern about the effects of recurrent hypoglycaemia and chronic hyperglycaemia on cognitive function. Because other biomedical factors may also increase the risk of cognitive decline, this study examined whether macrovascular risk factors (hypertension, smoking, hypercholesterolaemia, obesity), sub-clinical macrovascular disease (carotid intima-media thickening, coronary calcification) and microvascular complications (retinopathy, nephropathy) were associated with decrements in cognitive function over an extended time period.


METHODS
Type 1 diabetes patients (n = 1,144) who had completed a comprehensive cognitive test battery at entry into the Diabetes Control and Complications Trial were re-assessed at a mean of 18.5 (range: 15-23) years later. Univariate and multivariable models examined the relationship between cognitive change and the presence of micro- and macrovascular complications and risk factors.


RESULTS
Univariate modelling showed that smoking history was modestly associated with decrements in learning, memory, spatial information-processing and psychomotor efficiency; hypertension was associated with only psychomotor slowing. Multivariable modelling demonstrated that HbA(1c) level, and retinal and renal complications were each independently associated with decrements in psychomotor efficiency. In contrast, no macrovascular risk factors were significant after correcting for multiple comparisons. No interactions were found between these predictors and sex, severe hypoglycaemic events or presence of the APOE ε4 allele.


CONCLUSIONS
In relatively healthy, middle-aged adults with type 1 diabetes who had been followed for an average of 18.5 years, long-term metabolic control and microvascular factors are independently associated with a decline in cognitive function specifically affecting measures of psychomotor efficiency.


BACKGROUND
ClinicalTrials.gov NCT00360893.
Jacobson
A M
AM
Winthrop-University Hospital, Suite 300, 222 Station Plaza North, Mineola, NY 11501, USA. amjacobson@winthrop.org
Ryan
C M
CM
Cleary
P A
PA
Waberski
B H
BH
Weinger
K
K
Musen
G
G
Dahms
W
W
D000293:Adolescent; D000328:Adult; D003071:Cognition / Q000502:physiology*; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000503:physiopathology*; D003928:Diabetic Nephropathies / Q000150:complications / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000150:complications / Q000503:physiopathology; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000503:physiopathology; D008297:Male; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D055815:Young Adult
Atherosclerosis. 2007 May;192(1):138-47
16740268
Neuron. 2009 Mar 12;61(5):681-91
19285465
Diabetologia. 2003 Jul;46(7):940-8
12819900
Diabetes. 1997 Feb;46(2):271-86
9000705
Neurology. 2003 Sep 23;61(6):806-11
14504325
J Clin Exp Neuropsychol. 1987 Dec;9(6):665-79
3693528
Surv Ophthalmol. 2001 Jul-Aug;46(1):59-80
11525792
Ann Intern Med. 1996 Feb 15;124(4):379-88
8554246
Stroke. 2009 Oct;40(10):3180-5
19644063
Lancet Neurol. 2008 Feb;7(2):184-90
18207116
Diabetes Care. 2009 Mar;32(3):445-50
19151204
Psychoneuroendocrinology. 2007 Sep-Nov;32(8-10):1041-51
17884300
Clin Chem. 2005 Apr;51(4):753-8
15684277
Nat Rev Neurosci. 2008 Jan;9(1):36-45
18094705
N Engl J Med. 2000 Feb 10;342(6):381-9
10666428
N Engl J Med. 1993 Sep 30;329(14):977-86
8366922
Diabetes. 2008 Jun;57(6):1645-50
18332097
Diabetes. 2006 Jun;55(6):1800-6
16731845
Neurology. 2007 Mar 6;68(10):751-6
17339582
Diabetes. 2008 Nov;57(11):3083-9
18694971
Diabetes. 2006 Dec;55(12):3556-65
17130504
N Engl J Med. 2007 May 3;356(18):1842-52
17476010
Arch Gen Psychiatry. 2009 Aug;66(8):878-87
19652127
Stroke. 2009 May;40(5):1590-6
19265054
Eur J Pharmacol. 2008 May 6;585(1):88-96
18396273
Diabetologia. 2005 Dec;48(12):2460-9
16283246
Age Ageing. 2004 Jul;33(4):355-61
15136287
Atherosclerosis. 2007 Jan;190(1):143-9
16488420
N Engl J Med. 2003 Jun 5;348(23):2294-303
12788993
Stroke. 2006 Jan;37(1):82-6
16306463
Diabetologia. 2009 Mar;52(3):534-40
19096823
Percept Mot Skills. 1993 Jun;76(3 Pt 2):1219-30
8337069
J Anat. 2005 Apr;206(4):319-48
15817102
Stroke. 2002 Jun;33(6):1487-92
12052979
Diabetologia. 2007 Nov;50(11):2388-97
17764005
Diabetes. 1992 Jan;41(1):107-13
1727729
Diabetes. 2003 Jan;52(1):149-56
12502506
Neurobiol Aging. 2005 Dec;26 Suppl 1:21-5
16213627
Neuropsychol Rev. 2007 Sep;17(3):259-73
17690985
J Am Geriatr Soc. 2008 Mar;56(3):501-9
18179496
Clin Neuropsychol. 2002 Aug;16(3):373-80
12607149
Diabetes Care. 1999 Jan;22(1):99-111
10333910
Diabetes Care. 2005 Mar;28(3):726-35
15735218